|
rdf:type |
|
|
lifeskim:mentions |
|
|
pubmed:issue |
11
|
|
pubmed:dateCreated |
2009-5-12
|
|
pubmed:abstractText |
Hemagglutination-inhibition (HI) antibody titers correlate with protective immunity to seasonal influenza viruses. However, inactivated H5N1 influenza vaccines from Vietnam 2004 strains afford protection without producing high or even detectable HI antibodies.
|
|
pubmed:language |
eng
|
|
pubmed:journal |
|
|
pubmed:citationSubset |
AIM
|
|
pubmed:chemical |
|
|
pubmed:status |
MEDLINE
|
|
pubmed:month |
Jun
|
|
pubmed:issn |
0022-1899
|
|
pubmed:author |
|
|
pubmed:issnType |
Print
|
|
pubmed:day |
1
|
|
pubmed:volume |
199
|
|
pubmed:owner |
NLM
|
|
pubmed:authorsComplete |
Y
|
|
pubmed:pagination |
1629-37
|
|
pubmed:meshHeading |
pubmed-meshheading:19385735-Animals,
pubmed-meshheading:19385735-Antibodies, Viral,
pubmed-meshheading:19385735-Flow Cytometry,
pubmed-meshheading:19385735-Hemagglutination, Viral,
pubmed-meshheading:19385735-Influenza A Virus, H5N1 Subtype,
pubmed-meshheading:19385735-Mice,
pubmed-meshheading:19385735-Mice, Inbred BALB C,
pubmed-meshheading:19385735-Neuraminidase,
pubmed-meshheading:19385735-Orthomyxoviridae Infections,
pubmed-meshheading:19385735-Vaccines, Inactivated
|
|
pubmed:year |
2009
|
|
pubmed:articleTitle |
Protective immunity afforded by inactivated H5N1 (NIBRG-14) vaccine requires antibodies against both hemagglutinin and neuraminidase in mice.
|
|
pubmed:affiliation |
Department of Immunology, National Institute of Infectious Diseases, Tokyo, Japan. ytakahas@nih.go.jp
|
|
pubmed:publicationType |
Journal Article,
Research Support, Non-U.S. Gov't
|
